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Introduction
Hereditary spastic paraplegia (HSP) is a genetic disease charac-
terized by neurodegeneration of the long axons of spinal neu-
rons of the dorsal columns and cortical spinal tract, with clini  cal 
symptoms resulting from this pathology. HSP is a hetero-
geneous disorder both clinically and genetically with dominant, 
recessive, and X-linked forms linked to >20 loci (Fink, 2002). 
One of the most common forms of autosomal dominant HSP 
is caused by mutations in Spastin (SPG4; Hazan et al., 1999). 
We and others have shown that Spastin is a microtubule (MT)-
severing enzyme (Evans et al., 2005; Roll-Mecak and Vale, 2005), 
meaning that Spastin makes internal breaks in MTs. The mech-
anisms of enzyme assembly, tubulin recognition or engagement, 
and severing are unknown. Many disease-associated missense 
mutations in Spastin impair both ATPase and MT-severing ac-
tivities, suggesting that HSP and axon loss paradoxically result 
from failure of MT severing.
Spastin is a member of the AAA ATPase (ATPases asso-
ciated with various cellular activities) family (for review see 
  Hanson and Whiteheart, 2005). The defi  ning feature of these 
enzymes is the  250-amino-acid module known as the AAA 
ATPase domain. In the majority of cases examined, AAA pro-
teins assemble into ring-shaped hexamers, sometimes in an 
ATP-dependent manner. In part, this is because the ATP binding 
pockets are constituted from residues from adjacent monomers 
in the oligomer.
Many AAA proteins disassemble protein complexes with-
out destroying their substrates. For instance, NSF apparently 
unwinds the coiled coils that defi  ne the SNARE complex, re-
sulting in SNARE complex disassembly so that the individual 
SNARE components can be reused for successive rounds of 
membrane fusion (Sollner et al., 1993).
Particularly well understood AAA proteins are the so-
called translocators. These enzymes, whose members include 
the Clp family, are often involved in protein quality control. The 
hexameric forms of these proteins engage target proteins by rec-
ognizing C-terminal peptides (Gottesman et al., 1998) and pulling 
or translocating these polypeptides through the central pore of 
the hexamer (Hoskins et al., 1998; Ishikawa et al., 2001). Suc-
cessive cycles of ATP hydrolysis lead to unfolding of target pro-
teins and complete and directional translocation of the substrate 
through the pore often into an associated proteolytic machine 
(Weber-Ban et al., 1999; Reid et al., 2001). Therefore, action of 
the translocating type AAAs results in denaturation or destruc-
tion of the native target protein.
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pastin, an AAA ATPase mutated in the neurode-
generative disease hereditary spastic paraplegia, 
severs microtubules. Many other AAA proteins form 
ring-shaped hexamers and contain pore loops, which 
project into the ring’s central cavity and act as ratchets 
that pull on target proteins, leading, in some cases, to 
conformational changes. We show that Spastin assembles 
into a hexamer and that loops within the central pore rec-
ognize C-terminal amino acids of tubulin. Key pore loop 
amino acids are required for severing,   including one 
  altered by a disease-associated mutation. We also show 
that Spastin contains a second microtubule binding do-
main that makes a distinct interaction with micro  tubules 
and is required for severing. Given that Spastin engages 
the MT in two places and that both interactions are re-
quired for severing, we propose that severing occurs by 
forces exerted on the C-terminal tail of tubulin, which re-
sults in a conformational change in tubulin, which releases 
it from the polymer.
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Structural studies of several AAA proteins, particularly 
translocators, revealed the existence of loops that project into 
the pore cavity in the hexamer. In a hexamer, each monomer 
contributes two loops. Mutational analysis of many AAA pro-
teins has shown that pore loop integrity is critical for function. 
Pore loop 1 lies near the surface of the pore and contains a con-
served YVG motif also found in Spastin (Wang et al., 2001; 
Yamada-Inagawa et al., 2003; Siddiqui et al., 2004; Graef and 
Langer, 2006). Mutation of these residues often results in 
  retained ATPase activity and enzyme assembly but loss of 
  function. In the P4 phage packaging motor, the equivalent of 
pore loop 1 has been shown to alternate between “up” and “down” 
conformations throughout the ATPase cycle (Mancini et al., 
2004). With ClpA and ClpB (Schlieker et al., 2004; Hinnerwisch 
et al., 2005) or p97/VCP (DeLaBarre et al., 2006), cross-linking 
studies have shown that substrate proteins are in direct con-
tact with pore loop 1. These data suggest that pore loop 1 may 
engage target proteins and be responsible for translocation. 
Pore loop 2 lies deeper inside the pore. In translocators, pore 
loop 2 has not been cross-linked to target proteins, but mutations 
in this loop block function and sometimes lead to an inability 
to bind target proteins (Hinnerwisch et al., 2005; DeLaBarre 
et al., 2006). Although pore loops are present in AAAs that 
are not known to translocate target proteins, the contribu-
tion of these loops to the function of these enzymes is not as 
well investigated.
Here, we show that Spastin assembles into a hexamer in 
the presence of ATP, that hexameric but not unassembled Spastin 
recognizes the extreme C-terminal amino acids of its target pro-
tein, tubulin, and that this interaction is required for MT severing. 
Mutational analysis of the pore loops, including analysis of a 
disease-associated mutation in pore loop 2, shows that both 
pore loops are critical for MT severing and probably are directly 
involved in recognizing the extreme C terminus of tubulin. 
  Despite the fact that the tubulin C-terminal tail is present in tu-
bulin dimer, Spastin does not bind well to tubulin dimer com-
pared with MT polymer. In addition to the pore interaction with 
tubulin, we defi  ne an N-terminal MT binding domain (MTBD) 
in Spastin that mediates the attachment of Spastin to the MT. 
This interaction is also required for severing.
Results
N-terminal domains in Spastin 
are not required for MT severing
We have previously shown that recombinant Spastin severs 
MTs (Evans et al., 2005). To simplify the task of addressing the 
mechanism by which Spastin severs MTs and to produce a more 
soluble recombinant protein that expresses better in Escherichia 
coli, we fi  rst sought to defi  ne which domains of Spastin are 
  dispensable for MT severing. Like many other AAA proteins, 
Spastin contains a C-terminal AAA cassette (roughly aa 343–
616) and an N-terminal region (aa 1–342). Homology to other 
AAA proteins is only within the AAA domain. The N-terminal 
region consists of four subdomains (see Fig. 1 A for schematic): 
the Atlastin binding domain (Evans et al., 2006), the MIT domain, 
alternatively spliced exon 4 (Charvin et al., 2003), and as we 
show in Fig. 2, an MTBD that is both necessary for MT severing 
and suffi  cient for MT association.
To qualitatively assay MT severing, we exploited the fact 
that Spastin overexpression results in nearly complete loss of 
MTs (Errico et al., 2002; Evans et al., 2005). Expression of the 
∆1–227 deletion mutant resulted in loss of MTs, suggesting that 
the fi  rst 227 amino acids of Spastin are not required for severing 
activity (Fig. 2 A). Deletion of the fi  rst 279 amino acids of Spastin 
did not abolish severing (Fig. 2 A, ∆1–279 Spastin). However, 
Spastin lacking the fi  rst 328 amino acids did not sever MTs in 
transfected cells (Fig. 2 A, ∆1–328). In aggregate, the deletion 
experiments suggest that a region between residues 279 and 328 
is important for MT severing.
Unexpectedly, we found that recombinant Spastin lacking 
this region (aa 279–328) could still sediment with purifi  ed 
MTs in vitro (unpublished data). Therefore, we deleted a few 
more amino acids and produced recombinant Spastin proteins 
lacking either aa 1–227 (∆1–227 Spastin) or both aa 1–227 
Figure 1.  Schematic depiction of domain architecture of Spastin and con-
structs used in this study. (A) The numbers below each box represent the 
amino acid boundaries of individual domains/deletions. Numbering 
based on human Spastin. PL, pore loop. The column on the right indicates 
whether the mutant severs and/or binds to MTs. (B) Model of hexameric 
Spastin showing central pore and location of pore loops and N-terminal 
MTBD. The majority of the ring is formed by the AAA ATPase domain (purple). 
Image is looking down into the pore cavity. Each monomer of Spastin 
  contributes two pore loops. Pore loop 1 (yellow) lies near the mouth of the 
pore, whereas pore loop 2 (pink) resides deeper in the pore. The N-terminal 
region projects from the ring. The cartoon is loosely based on structures of 
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and aa 270–328 (called ∆MTBD Spastin; Fig. 1 A). Using a 
previously published sedimentation assay for MT destruction 
(Evans et al., 2005) where MTs are recovered in the pellet and 
released tubulin in the supernatant after centrifugation, we   
found that ∆1–227 Spastin could associate with MTs in the ab-
sence of ATP and caused MT disassembly in the presence of 
ATP (Fig. 2 B). In contrast, ∆MTBD Spastin neither bound nor 
severed MTs, demonstrating that aa 270–328 are necessary for 
MT severing in vitro. Consistent with this in vitro data, over-
expression of ∆MTBD Spastin in cells did not result in MT loss 
(Fig. 2 B). We next examined whether the MTBD was suffi  cient 
to confer MT association both in cells and in vitro. In transfec-
tion experiments, 1–328 stop Spastin but not 1–279 stop Spastin 
decorated MTs, suggesting that amino acids 280–328 are im-
portant for MT binding (Fig. 2 C).
We next wanted to examine whether this domain was suf-
fi  cient for direct MT interaction. We found that we could use the 
heterobifunctional chemical cross-linker ethyl-3-(dimethyl-
aminopropyl)-carbodiimide (EDC) to detect a direct inter-
action between Spastin and tubulin/MTs (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200610072/DC1). This 
cross-link did not require ATP. A GST fusion protein containing 
only aa 227–279 of Spastin was not able to cross-link to MTs 
(Fig. 2 D). However, a fusion protein containing aa 227–328 
of Spastin was able to cross-link to MTs, suggesting that this 
MTBD is suffi  cient for direct interaction with MTs. Despite the 
fact that GST-227-328 Spastin could be cross-linked to MTs, 
it did not sediment with MTs (unpublished data). This may 
suggest a low-affi  nity interaction.
Together, these data suggest that an N-terminal MTBD 
encompassing aa 270–328 in Spastin is also important for MT 
severing. This domain also appears to be suffi  cient for MT asso-
ciation in a nucleotide-independent manner. We made internal 
deletions within this region to refi  ne it further (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200610072/DC1) 
and found that both halves of this domain seem to mediate MT 
association in cells but one half appears more critical for MT 
severing than the other. Consistent with our results, others have 
shown that deletion of the entire N-terminal region preceding 
the AAA domain in Drosophila melanogaster Spastin resulted 
in an enzyme incapable of MT severing (Roll-Mecak and Vale, 
2005). They did not address whether this N-terminal domain 
bound to MTs directly.
Our data demonstrating that Spastin lacking the fi  rst 270 
amino acids can still associate with MTs and sever in vivo 
seem inconsistent with the claim by others of a MTBD in the 
fi  rst 269 amino acids of Spastin (Errico et al., 2002). Those ex-
periments did not use purifi  ed proteins, and it is possible that 
Figure 2.  Identiﬁ  cation of an N-terminal MTBD in Spastin. (A) Cos-7 cells 
transfected with plasmids encoding YFP-Spastin (green) with the indicated 
amino acids deleted were ﬁ  xed and stained for tubulin (red). Deletion of 
the ﬁ  rst 227 or even the ﬁ  rst 279 amino acids did not abolish severing, as 
the transfected cell lacked MTs (compared with surrounding nontransfected 
cells). In contrast, deletion of the ﬁ  rst 328 amino acids did abolish severing 
activity, as the transfected cell still has an MT array. This suggested that 
the approximate boundaries for a MTBD are between aa 280 and 328. 
(B) Recombinant ∆1–227 binds to taxol-stabilized MTs in the absence of ATP 
and severs them in the presence of ATP. ∆1–227 Spastin was incubated 
with taxol-stabilized MTs either in the absence or presence of ATP as 
  indicated. MTs were recovered in the pellet (P) fractions after centrifugation. 
In the absence of ATP, some of the ∆–1227 Spastin bound to MTs. In the pres-
ence of ATP, most of the tubulin was recovered in the supernatant fraction, 
indicative of MT disassembly. Most of the Spastin was recovered in the super-
natant as well, except for a small fraction that sedimented nonspeciﬁ  cally. 
In contrast, ∆MTBD Spastin neither binds nor severs MTs, even in the pres-
ence of ATP. ∆MTBD Spastin was incubated with ATP, as indicated, in 
  either the absence (left two lanes) or presence of taxol-stabilized MTs (right 
two lanes). Samples were centrifuged, and pellet and supernatant fractions 
were examined by SDS-PAGE. A small percentage of the mutant Spastin 
sedimented nonspeciﬁ  cally in the absence of MTs. Note that there was no 
speciﬁ  c binding of the mutant Spastin to MTs (no additional Spastin in the 
pellet fraction with the MTs) and that the vast majority of the tubulin was 
  recovered in the pellet, indicating that severing did not occur. In the gel on 
the right, samples were all from the same experiment but were run on op-
posite ends of a single gel and so are shown separately here. The micro-
graph shows that cells transfected with a plasmid encoding YFP-∆MTBD 
Spastin still have MT, arrays showing that the enzyme does not sever in 
cells (compare to ∆–1227 Spastin in Fig. 2 A). (C) To determine whether 
the MTBD is sufﬁ  cient to confer MT association, stop codons were intro-
duced at the indicated positions in the full-length YFP-Spastin cDNA, and 
the indicated plasmids were used to transfect cells. 1–279 stop Spastin did 
not decorate MTs (inset shows MTs). In contrast, 1–328 stop Spastin deco-
rated MTs, suggesting that a region between 280 and 328 may be sufﬁ  -
cient for MT binding. (D) Chemical cross-linking demonstrates an interaction 
between the MTBD and MTs. Taxol-stabilized MTs were incubated with 
Spastin, GST-227-279 Spastin, or GST-227-328 Spastin, as indicated in 
the ﬁ   gure, in the presence of EDC as indicated. The Coomassie blue–
stained gel shows that neither GST fusion protein cross-linked to itself in the 
absence of MTs (lanes 3 and 4) but that GST-227-328 Spastin cross-linked 
nearly as efﬁ  ciently to MTs (lane 8; cross-link marked by two asterisks), as 
did Spastin (lane 10; cross-link marked by three asterisks). The cross-link 
marked by a single asterisk is a tubulin–tubulin cross-link (see Fig. S2, 
available at http://www.jcb.org/cgi/content/full/jcb.200610072/DC1).JCB • VOLUME 176 • NUMBER 7 • 2007  998
the observed MT association in crude cell lysates was indirect, 
perhaps mediated by endogenous Spastin in the cells. Our 
 dele tion  results  suggested  that  ∆1–227 Spastin severs MTs. 
Compared with recombinant full-length Spastin, this deletion 
mutant expressed much better, was more soluble, and was less 
prone to aggregate. Therefore, we characterized this version of 
recombinant Spastin and, unless otherwise indicated, all fur-
ther experiments and effects of point mutations were examined 
in this “backbone.”
We performed ATPase assays for ∆1–227 Spastin and 
calculated the Km and Vmax for the enzyme (Fig. 3 A). Because 
these values were previously determined for full-length Spastin 
using a Lineweaver-Burke plot (Evans et al., 2005), we recal-
culated Km and Vmax using the nonlinear regression method; 
these numbers are also shown in Fig. 3 A. ∆1–227 Spastin 
severed MTs in a videomicroscopy-based assay that we had 
previously used to study Spastin (Fig. 3 B). We conclude that 
the fi  rst 227 amino acids of Spastin are not required for MT 
severing. Although ∆1–227 Spastin severs MTs and has similar 
ATPase kinetics compared with full-length protein, severing 
as assessed by the videomicroscopic assay is not amenable 
to kinetic analysis in our experience. Therefore, we cannot 
ascertain whether the truncated enzyme severs as well as full-
length protein.
The extreme C-terminal residues 
of 𝗂-tubulin are recognized by Spastin
Limited proteolysis of MTs with subtilisin, which cleaves off 
small peptides from the extreme C terminus of α- and β-tubulin 
(Paschal et al., 1989), renders them resistant to severing by 
Spastin (Roll-Mecak and Vale, 2005). Therefore, we hypothe-
sized that Spastin might engage the free C terminus of tubulin 
during the severing reaction. Examination of MT structure shows 
that the last  100 amino acids of α- and β-tubulin project 
from the surface of the MT primarily as two helices (Nogales 
et al., 1998, 1999). The last several amino acids of α- and β-tubulin 
are unstructured and are not resolved in crystal structures. 
We prepared recombinant GST fusion proteins representing 
the C-terminal 104 amino acids of α-tubulin. Because of 
  posttranslation detyrosination of α-tubulin, we prepared tails 
ending either in Tyr or Glu and predicted that Spastin should 
bind directly to these tails. Accordingly, we immobilized the 
GST–tubulin tails on glutathione–Sepharose and found that 
wild-type (WT) Spastin did not bind to the bead-immobi  lized 
  tubulin tails (Fig. 4 A). Given that Spastin can associate with 
MTs in vitro in the absence of ATP (Fig. 2 B), this result 
was surprising.
Because WT Spastin could not bind to the tubulin tail and 
because AAA proteins harboring a canonical Walker B motif 
point mutation (E442Q in Spastin) often remain kinetically 
trapped on their cellular target proteins (Dalal et al., 2004; Evans 
et al., 2005), we tested whether E442Q Spastin could bind the 
tubulin tail. Indeed, E442Q Spastin bound to the tail only in the 
presence of ATP. E442Q Spastin bound equally well to both Glu 
and Tyr tails. E442Q Spastin did not bind well to truncated 
GST–tubulin tails lacking the last 22 amino acids (Fig. 4 B), 
suggesting that the most C-terminal region of these peptides are 
important for Spastin binding.
This ATP-dependent binding appears to represent a distinct 
interaction with tubulin as compared with the ATP-independent 
interaction between tubulin and the N-terminal MTBD dis-
cussed earlier (Fig. 2). In other AAA proteins, the E to Q Walker B 
mutation allows for ATP binding but not hydrolysis, trapping 
the oligomeric form of the enzyme. This suggests that oligo-
meric Spastin is binding to the tubulin tail.
Spastin assembles into a hexamer
To specifi  cally test whether Spastin can assemble into a homo-
oligomer and whether the E442Q mutation traps the oligomer as 
a stable complex, we analyzed Spastin by gel fi  ltration. E442Q 
Spastin, which is predicted to bind but not hydrolyze ATP, 
  assembled into a homooligomer in an ATP-dependent manner 
(Fig. 4 C, compare top two panels). In contrast to the relatively 
symmetrical elution profi  le of oligomeric Spastin shown in 
Fig. 4 C, in some experiments, the peak was less symmetrical 
and left shifted. Neither ATP nor ATPγS trapped WT Spastin as 
a stable oligomer. We presume that WT Spastin can form a hex-
amer but that even with ATPγS, the hexamer is not as stable as 
that formed by the E442Q mutant.
To more accurately characterize the Spastin homooligomer, 
we collected the high molecular mass oligomer fraction of 
E442Q Spastin obtained by gel fi  ltration and analyzed the 
Figure 3.  Biochemical characterization of 𝖫1–227 Spastin. (A) An aliquot 
of puriﬁ  ed ∆1–227 Spastin was analyzed by SDS-PAGE. ATPase activity 
as a function of ATP concentration is shown. The data was ﬁ  t to a curve 
  using Prism 4.0 software, and nonlinear regression analysis was used to 
calculate Km and Vmax. Km and Vmax were also recalculated from our original 
data (Evans et al., 2005) for full-length Spastin using nonlinear regression 
method rather than the Lineweaver-Burke plot originally used. Error bars 
  indicate ± SD. (B) Spastin ∆1–227 severs MTs. Rhodamine-labeled taxol-
stabilized MTs (1 μM tubulin) were immobilized in a perfusion chamber, 
and 400 nM Spastin with 1 mM ATP was added. Four frames from the time 
lapse are shown with the time stamped (min:s) in each frame. Note the ap-
pearance of internal breaks indicative of severing. Representative breaks 
are indicated by arrowheads. Conditions are as published previously 
(Evans et al., 2005).MECHANISM OF MICROTUBULE SEVERING BY SPASTIN • WHITE ET AL. 999
  protein complex by sedimentation velocity in the presence of 
ATP. Fig. 4 D shows that the normalized sedimentation coeffi  -
cient distributions obtained over a broad concentration range 
are nearly superimposable, with a major peak at 7.6 ± 0.05 
Svedbergs (uncorrected). Thus, Spastin forms a stable, non-
equilibrating oligomer over the concentration range examined. 
As described in Materials and methods, we also calculated the 
translational diffusion constant from the sedimentation velocity 
data. We then used the Svedberg equation to calculate the mo-
lecular mass of Spastin. The sedimentation data fi  t to a mean 
mass of 250 ± 10 kD, which agrees well with a predicted hex-
amer mass of 258 kD (∆1–227 Spastin has a mass of 43 kD). 
We conclude that Spastin assembles into a hexamer in the pres-
ence of ATP.
The binding data in Fig. 4 A suggest that the hexameric 
form of Spastin binds to the tubulin tail. In light of the assembly 
data, it is likely that the WT Spastin hexamer dissociates upon 
ATP hydrolysis, whereas the E442Q hydrolysis-defi  cient mu-
tant remains trapped as a stable hexamer. We imagine that WT 
Spastin does form a hexamer and binds transiently but that we 
cannot detect binding on account of hexamer instability.
Spastin pore loops are required for MT 
severing and recognition of the C-terminal 
amino acids in tubulin
Why might hexameric but not monomeric Spastin bind to the 
tubulin tails? Assembly of AAA proteins results in the forma-
tion of a central pore (Fig. 1 B). Because pore loops in some 
AAA proteins have been shown to directly contact substrate 
proteins, we hypothesize that the observed binding to the tubulin 
tails is mediated by pore residues in Spastin and that mutations 
in these pore loops should abrogate the tubulin tail–Spastin 
  interaction and MT-severing activity (Fig. 5 A). We introduced 
several pore loop mutations into E442Q Spastin and asked 
whether these pore mutations could suppress the ATP-dependent 
binding to the tubulin tails (Fig. 5 B). Residues 415–417 in 
Spastin constitute the YVG motif in pore loop 1 (Fig. 5 A). 
Many groups have found that the aromatic residue in pore loop 1 is 
crucial for function (Yamada-Inagawa et al., 2003; Siddiqui 
et al., 2004; Park et al., 2005). E442Q/Y415A Spastin did not 
bind to the GST–α-tubulin tails (Fig. 5 B).
Because the tubulin tail is extremely acidic, we predicted 
that basic amino acids in pore loop 2 might be important for tail 
binding. Compared with some other AAA proteins, pore loop 2 in 
Spastin lacks a conserved acidic residue and harbors an extra 
basic residue (Fig. 5 A). Therefore, we engineered missense 
mutations in pore loop 2: two that alter charged amino acids 
(R451G and A457E) and one representing a disease-associated 
mutation (C448Y; Hazan et al., 1999). Fig. 5 B shows that 
C448Y/E442Q Spastin but not R451G/E442Q or A457E/E442Q 
Spastin bound to the GST–α-tubulin tail. The Arg residue that 
we mutated is not conserved in all Spastins (e.g., D. melanogaster 
Spastin). However, in dSpastin, there is a Lys residue in the loop 
at a more C-terminal position, and the “charge balance” in the 
loop is therefore the same as human Spastin.
Tubulin is a heterodimer, and we therefore examined the 
binding of Spastin to β3-tubulin tails. We chose to examine this 
neuron-specifi  c β-tubulin isoform both because HSP is a neu-
ronal disorder and because, although, like α-tubulin, it has an 
acidic tail, the sequence, particularly the last four amino acids, 
is quite distinct from α-tubulin (Fig. 5 C). Similar to the results 
for the α-tubulin tail, we found that E442Q Spastin bound to 
GST–β3-tubulin tail in an ATP-dependent manner (Fig. 5 D). 
As with the α-tubulin tail, introduction of the Y415A, R451G, 
or A457E pore loop mutations into E442Q Spastin abolished 
binding. In contrast to the result obtained with α-tubulin tail, 
the C448Y HSP-associated mutation abrogated binding to the 
β3-tubulin tail.
In summary, mutations in both pore loops 1 and 2 can 
  affect tail binding. Importantly, compared with many disease 
and engineered mutations in Spastin that we previously examined 
(Evans et al., 2005), the pore loop mutants all retained some 
ATPase activity (Fig. 5 E). Also, we found that R451G/E442Q 
and A457E/E442Q Spastin could still oligomerize in the presence 
Figure 4.  Spastin binds the C-terminal tail of tubulin and hexamerizes in 
an ATP-dependent manner. GST–tubulin tails (ending in either Tyr or Glu) 
were immobilized on glutathione–Sepharose. WT or E442Q Spastin was 
applied in either the absence or presence of ATP. After binding and washing 
of beads, samples were analyzed by SDS-PAGE. (A) E442Q but not WT 
Spastin binds in the presence of ATP. The ﬁ  rst lane of each series shows an 
aliquot (20% of total) of Spastin starting material. About 25–33% of the 
Spastin bound to the tails. (B) Compared with full-length tail, deletion of the 
last 22 amino acids from the tail nearly completely abrogates the binding 
of E442Q Spastin. (C) Puriﬁ  ed ∆1–227 Spastin was subjected to gel ﬁ  ltra-
tion chromatography on a Superdex 200 column. 0.4-ml fractions were 
analyzed by SDS-PAGE and Coomassie blue staining. Elution positions of 
size standards are shown. Elution times in minutes are shown below each 
fraction. (D) Sedimentation velocity analysis of E442Q Spastin in the pres-
ence of ATP. Normalized g(s*) versus s* plots were obtained using the 
  program DcDt+ (Philo, 2000, 2006). Sample concentrations: 0.94 mg/ml 
(black), 0.51 mg/ml (blue), 0.22 mg/ml (red), and 0.08 mg/ml (green).JCB • VOLUME 176 • NUMBER 7 • 2007  1000
of ATP (Fig. 5 F). The ATPase measurements and gel fi  ltra-
tion experiments suggest that pore loop mutations do not pre-
vent pore assembly and that the point mutations in pore loops 
more or less specifi  cally prevent tubulin tail binding without 
globally disrupting Spastin. We conclude that the tubulin 
tail likely binds in the pore in hexameric Spastin in a loop-
 dependent  manner.
If the tubulin tail binds inside the central pore of the 
  Spastin hexamer, the C-terminal Tyr residue in the tubulin tail 
should be relatively resistant to proteolysis by carboxypeptidase 
A (CpA), which specifi  cally removes this Tyr from α-tubulin 
(Chapin and Bulinski, 1991). We observed partial protease 
  protection, consistent with this notion (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200610072/DC1).
Pore loop mutations in Spastin 
inhibit MT severing
If the pore–tubulin tail interaction is important for MT severing, 
the pore mutations should impair Spastin’s MT-severing activity, 
even though the enzymes can hydrolyze ATP (Fig. 5 E). Indeed, 
when cells were transfected with plasmids encoding YFP-
Spastin harboring pore mutations, severing did not occur 
(Fig. 6 A). Instead, the mutant Spastin proteins deco  rated MTs. 
Similarly, using the previously described sedimentation assay, 
recombinant Spastin proteins harboring pore loop mutations 
(Y451A, C448Y, and R451G) did not sever MTs in the pres-
ence of ATP (Fig. 6 B), as nearly all of the tubulin remained 
in the pellet as polymer. Similar results were obtained for the 
A457E mutation (not depicted). Note that a small fraction of 
each protein sedimented into the pellet only in the presence 
of MTs.
A C-terminal tubulin polypeptide acts 
as a competitive inhibitor of Spastin
Because we showed that pore loops engage the tubulin tail 
and that mutations that prevent this interaction also prevent 
  severing, we further predicted that C-terminal peptides derived 
from tubulin should act as competitive inhibitors of Spastin-
mediated MT severing. We incubated the GST–tubulin tail fusion 
protein with Spastin and taxol-stabilized MTs in either the pres-
ence or absence of ATP, as indicated in Fig. 6 C. We used the 
previously described MT sedimentation assay to monitor MT 
disassembly. In the absence of GST–tubulin tail, Spastin effec-
tively severed MTs. In contrast, when GST–tubulin tail was 
added in 10-fold molar excess compared with tubulin, severing 
was substantially blocked. Truncated GST–tubulin tail lacking 
Figure 5.  Mutations in pore loops 1 and 2 affect 
  tubulin tail recognition. (A) Sequence alignments of 
part of the AAA domain from several AAA proteins. 
Alignments are from Karata et al. (1999). Pore loop 1 
is underlined and contains the YVG motif (green). This 
loop, which projects into the pore near the “mouth,” 
lies between sheet β2 and helix α3 in AAA domains. 
Pore loop 2 projects into the pore cavity but lies 
deeper in the pore and follows the Walker B motif 
(DEVD in Spastin) and lies between this motif and 
  helix α4 in the AAA domain. Amino acids mutated in 
pore loop 2 are marked by asterisks. (B) Effect of pore 
loop mutations on α-tubulin C-terminal tail binding. 
(left) Although the pore loop 1 mutation (Y415A) did 
not bind the α-tubulin tail, the HSP-associated pore 
loop 2 mutation (C448Y) did not affect tail binding. 
(right) Either elimination of a basic residue (R451G) 
or introduction of an acidic residue (A457E) in pore 
loop 2 abolishes tail binding to both Glu (E) and Tyr (Y) 
tails. The tail binding assay is as described in Fig. 4. 
In all cases, the indicated pore loop mutations were 
engineered into E442Q Spastin and we were asking 
whether the pore loop mutations abolished binding 
of hexamerized Spastin. (C) Partial amino acid se-
quences of mouse α2- and β3-tubulin tails are shown. 
Note the differences at extreme C terminus. (D) Bind-
ing of E442Q Spastin to the β3-tubulin tail and the 
  effects of pore loop mutations. Samples marked L 
  represent 20% of the input Spastin. As a positive con-
trol, lane 2 shows binding to the α2-tubulin tail. Lanes 
3 and 4 show that E442Q Spastin binds to the β3-
  tubulin tail in an ATP-dependent manner. As with the 
α tail, the YA, RG, and AE mutants do not bind. Although 
C448Y binds the α2 tail, it does not bind to the β3 
tail. (E) Relative ATPase activities of Spastin proteins 
harboring pore loop mutants. Error bars indicate ± SD. 
(F) Selected pore loop mutants that are impaired in 
  tubulin tail binding are not impaired in oligomer 
  formation. Gel ﬁ  ltration analysis performed in the 
presence of ATP with the indicated mutant Spastin pro-
teins shows that homooligomerization is not abolished by the pore loop mutations. Because we only detect stable oligomer formation with E442Q Spastin, 
we introduced the R451G or A457E mutations into E442Q Spastin. Note that both mutant proteins assemble (peak eluting around minutes 28–30). 
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the C-terminal 22 amino acids did not act as a competitive in-
hibitor of Spastin. Although the last 22 amino acids are neces-
sary for severing, a fusion protein consisting only of the 22 
amino acids of tubulin fused to GST did not act as a competitive 
inhibitor (unpublished data). This may indicate that the rest of 
the tubulin tail is important or that when expressed alone, the 
last 22 amino acids of the tail are not properly ordered. The ex-
periment in Fig. 6 C was performed with tubulin tail ending in 
Tyr, and similar results were obtained with peptides terminating 
in Glu (not depicted).
Spastin interacts poorly with 
nonpolymerized tubulin
Because the tubulin tails are present on nonpolymerized tubulin 
heterodimer, we might have predicted that Spastin, particularly 
the hexameric form, would interact with nonpolymerized tubu-
lin heterodimer. To test this idea, GST-E442Q Spastin was im-
mobilized on glutathione agarose, and tubulin was added in the 
presence of ATP (Fig. 7 A). In contrast to the tail binding exper-
iments (Fig. 4 A), where about one third of the added Spastin 
could be captured on tubulin tail beads, only negligible amounts 
of tubulin heterodimer were captured on GST-Spastin beads. 
This suggested that Spastin only interacts poorly, if at all, with 
tubulin dimer. Consistent with this notion, soluble tubulin dimer 
does not cofractionate with hexameric E442Q Spastin by gel 
fi   ltration analysis (unpublished data). These binding studies 
suggest that hexameric Spastin does not bind tubulin well de-
spite the presence of the tail. This may indicate that the tails are 
perhaps more accessible to Spastin when tubulin is polymerized 
in a MT or that Spastin plays a role in exposing the tail to the 
pore loops.
Also, as mentioned earlier, we can detect interaction of 
Spastin with tubulin using the chemical cross-linker EDC 
(Fig. S1). We compared the effi  ciency of Spastin cross-linking 
obtained using MTs to that obtained using nonpolymerized tu-
bulin and found that cross-linking to polymer is much more 
 effi  cient than to nonassembled tubulin, again suggesting that 
Spastin interacts better with MTs (Fig. 7 B, compare cross-links 
in lanes 4 and 8).
Discussion
Our deletion analysis revealed the existence of an N-terminal 
MTBD in Spastin (aa 270–328) that is required for MT-severing 
activity in vivo and in vitro. Additionally, this domain may be 
Figure 6.  Pore loop mutations affect MT-severing activity. (A) Pore loop 
mutations abolish MT severing in vivo. Although overexpression of YFP-
Spastin results in MT loss (Fig. 2 A), overexpression of Spastin harboring 
pore loop mutations (green) did not (tubulin shown in red). Instead, these 
mutant proteins decorate a subset of MTs, as do many other Spastin 
mutants (Evans et al., 2005). (B) Pore loop mutations abolish MT severing 
in vitro. The indicated mutant Spastin proteins were incubated with ATP in 
either the absence or presence of taxol-stabilized MTs. After incubation, 
samples were centrifuged. In contrast to WT Spastin, which releases sev-
ered tubulin that is recovered in the supernatant (S) fractions after centrifu-
gation (Fig. 2 B), these mutants do not sever. MTs are in the pellet (P) 
fractions. Mutant proteins did not sediment in the absence of MTs. A frac-
tion of each protein sedimented with the MTs. (C) Peptides corresponding 
to the C-terminal tail of tubulin are competitive inhibitors of MT severing. 
Taxol-stabilized MTs were incubated with Spastin and ATP as indicated. 
Where indicated, puriﬁ  ed GST–tubulin tail (GST fused to the C-terminal 
104 amino acids of α-tubulin) or GST–tubulin tail lacking the C-terminal 22 
amino acids was added as a competitive inhibitor at 10-fold molar excess 
compared with tubulin (threefold molar excess compared with Spastin hex-
amer assuming all Spastin oligomerizes). After 15 min at 37°C, MTs were 
separated from released tubulin by centrifugation as described pre-
viously (Evans et al., 2005). Severing activity is evident by appearance of 
more tubulin in supernatant fractions. Remaining MTs are recovered in 
the pellet.
Figure 7.  Spastin interacts only poorly with nonpolymerized tubulin. 
(A) GST-E442Q Spastin was incubated with ATP and immobilized on 
  glutathione–Sepharose. 12 μg tubulin was added to 6 μl bead slurry 
contain  ing 12 μg Spastin in a volume of 100 μl. After incubation for 30 min 
at room temperature, beads were washed three times. Almost none of 
the   tubulin bound to the immobilized Spastin (lane 2). Lane 1 shows 20% 
of the tubulin load. These two lanes are from the same experiment but were 
run on opposite ends of the same gel and so are shown separately here. 
(B) Equivalent amounts of nonpolymerized tubulin (lanes 1–4) or taxol-
  stabilized MTs (lanes 5–8) were incubated with E442Q Spastin, ATP, and 
EDC, as indicated in the ﬁ  gure. The Coomassie blue–stained gel shows 
that Spastin only cross-links weakly to nonpolymerized tubulin (lane 4) 
compared with MT polymer (lane 8). The cross-link marked by the asterisk 
is uncharacterized (see Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200610072/DC1).JCB • VOLUME 176 • NUMBER 7 • 2007  1002
suffi  cient for MT association. Analysis of this region of Spastin 
did not reveal any homology to any known protein or functional 
motif. Although Katanin has an MTBD preceding its AAA 
  domain, there is no homology between the N terminus of Spastin 
and Katanin. In fact, the only region of homology between these 
MT-severing proteins is in the AAA ATPase domain.
Our deletion analysis of the N-terminal region of Spastin 
also revealed that the fi  rst three subdomains in the N terminus 
of Spastin encompassing the fi  rst 227 amino acids are not re-
quired for MT severing. Previously, we (Evans et al., 2006) and 
others (Sanderson et al., 2006) found that Atlastin binds to a re-
gion in the fi  rst 116 amino acids of Spastin. Atlastin, an integral 
membrane GTPase, is encoded by another autosomal dominant 
HSP gene. We hypothesize that Spastin-interacting proteins, 
such as Atlastin, binding to the fi  rst 227 amino acids of Spastin 
might serve to localize Spastin to sites of activity (Evans et al., 
2006). Because we mapped an MTBD between aa 270 and 328, 
it is unlikely that known Spastin binding proteins interacting 
with regions between aa 1 and 227 would interfere with MT 
severing. This is consistent with the observation that Atlastin 
binding does not appear to regulate MT severing by Spastin 
(Evans et al., 2006).
We demonstrated that Spastin can assemble into a hex-
amer during its ATPase cycle. This is signifi  cant because Vps4, 
another AAA protein closely related to Spastin, has been pro-
posed to assemble into larger oligomers such as 12 mers rather 
than hexamers (Babst et al., 1998; Scott et al., 2005). Although 
slowly hydrolyzable ATP analogues allow for trapping of 
some WT AAA ATPases as oligomers, this is not the case for 
Spastin (Fig. 4 C). Similarly, Katanin (Hartman and Vale, 
1999) and Vps4 cannot be trapped as stable oligomers with 
ATP. Instead, the demonstration of homooligomeric forms of 
these enzymes also necessitated the use of the Walker B E to Q 
mutation. Together with Fidgetin, Spastin, Katanin, and Vps4 
constitute the meiotic subfamily of AAA ATPases (Frohlich, 
2001), and in this respect, this subgroup appears distinct from 
other AAA proteins.
Subtilisin treatment of MTs, which removes small pep-
tides from the C terminus of α- and β-tubulin, renders MTs re-
sistant to severing by both Spastin and Katanin (McNally and 
Vale, 1993; Roll-Mecak and Vale, 2005), the other known AAA 
ATPase that severs MTs. This prompted us to investigate the 
role of the tubulin C terminus in MT severing. Our results show 
that pore loops in hexameric Spastin recognize the extreme 
C terminus of its target protein (tubulin) and that this interaction 
is critical for MT severing. Whether Katanin recognizes tubulin in 
a similar manner is not known. Several microtubule-associated 
proteins and motor proteins also bind to the tubulin tail; this 
raises the possibility that certain microtubule-associated pro-
teins may protect MTs from severing as proposed (Baas et al., 
2005; Qiang et al., 2006).
Though the role of pore amino acids has been well studied 
in translocating AAA proteins involved in protein quality con-
trol, their role in other AAA proteins is not as well understood. 
A pore loop 1 mutation in Vps4 abolishes retroviral budding in 
a cell-based assay (Scott et al., 2005), just as a similar mutation 
in Spastin abolished severing. Our analysis of pore loop 2 in 
Spastin reveals that it plays a critical role in severing and in 
  tubulin C-terminal tail recognition, akin to the role of pore loop 2 
in ssrA tag recognition (Hinnerwisch et al., 2005). The C448Y 
disease-associated mutation uncouples ATPase from severing 
activities (Fig. 5 E and Fig. 6, A–C) and binds to the α-tubulin 
tail (Fig. 6 B). Interestingly, it cannot bind to the β3-tubulin tail 
(Fig. 6 C). Thus, even in non-Clp type AAA ATPases, pore 
loops are critical for function and for target protein recognition. 
Even though pore loops are present in unassembled Spastin, 
hexamerization is important for stable, robust tail binding. This 
could mean that there is simultaneous engagement of the tail by 
more than one loop or that the loops adopt different structures in 
the hexameric Spastin.
In transfected cells, pore loop mutations in Spastin, 
whether they abolish tail binding or not, result in Spastin pro-
teins that decorate MTs. Therefore, it is probable that MT asso-
ciation with these mutants occurs via the N-terminal MTBD 
and that the enzyme assembles and perhaps hydrolyzes ATP. 
However, we imagine that severing fails to occur either because 
the tubulin tail cannot engage the pore loop (YA, RG, or AE for 
α- and β-tubulin and these plus C448Y for the β-tubulin tail) or 
the normal response of the AAA ring to the engagement is 
blocked because of the mutated pore loops (CY). In either case, 
the protein apparently does not release from or sever the MTs.
Spastin lacking the N-terminal MTBD domain does not 
sever or decorate MTs despite having intact pore loops. This 
suggests that although tubulin tail–loop interaction is necessary 
for severing, this additional Spastin tubulin interaction must 
also be necessary for MT severing. Although ∆270–328 Spastin/
E442Q can hexamerize and hydrolyze ATP, it could not bind to 
the GST–α-tubulin tails (Fig. S4, available at http://www.jcb.org/
cgi/content/full/jcb.200610072/DC1). The reason for this is not 
clear but may suggest that the N-terminal MTBD–MT inter-
action is important in positioning the hexamer such that the 
Figure 8.  Model. (A) Unassembled Spastin can associate with MT polymer 
by virtue of the N-terminal MTBD. This interaction is not ATP dependent. 
ATP results in assembly of the hexamer and pore formation. The tubulin 
tails, which project from the surface of the MT polymer, bind to the pore 
loops (tails not drawn on all tubulins for clarity). This binding is ATP 
  dependent. Thus, Spastin can engage the MT in two distinct places. (B) The 
orientation of the ring on MTs is unclear. Two possible orientations are 
shown. The number of N-terminal MTBDs simultaneously in contact with the 
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  tubulin tail is pore accessible or that this MTBD actually plays 
a role in exposing that tail to the pore. We do not know where 
the N-terminal MTBD contacts the MT.
We have seen that purifi  ed recombinant Spastin can bind 
MTs. This includes WT enzyme as well as mutants that are pre-
dicted not to bind ATP (e.g., K388A Spastin) or hydrolyze ATP 
(e.g., E442Q; Evans et al., 2005). Thus far, only deletion of 
the N-MTBD prevents MT association in vitro and in vivo. In 
contrast, when mutant versions of Spastin are overexpressed in 
cells, two distinct patterns are observed. Most mutants analyzed 
in this and past work (Evans et al., 2005) do not sever MTs. 
However, some mutant proteins decorate MTs (e.g., E442Q and 
pore loop mutants), whereas others do not even though they 
bind in vitro (e.g., K388A and R499C; Evans, et al., 2005). We 
imagine that decoration of MTs in cells refl  ects more than mere 
binding and may refl  ect kinetic trapping of hexameric Spastin 
on MTs. Because E442Q forms an ATP-dependent oligomer, it 
is possible that this mutant protein assembles into a hexamer on 
MTs but, because it cannot hydrolyze the bound ATP, remains 
kinetically trapped on the MT, resulting in decoration. Interest-
ingly, the pore loop mutant Spastins decorate MTs even though 
they can hydrolyze ATP, albeit not quite as well as WT enzyme. 
This may imply that, although necessary for release, comple-
tion of an ATPase cycle is not suffi  cient to result in release from 
the MT.
Fig. 8 shows a schematic of the two distinct interactions 
Spastin makes with MTs. We propose that Spastin exerts force 
on the MT in part by engagement of the tubulin tail by Spastin’s 
pore. Severing could be achieved by pulling the tail into the 
pore. In this model, the N-MTBD would merely anchor the hex-
amer and severing would be analogous to untying a shoelace by 
pulling on a slipknot. Alternatively, the importance of the tail 
binding could be that relative motions occur between the two 
sites where Spastin is anchored to an MT. Soluble tubulin has 
a curved conformation but has a straight conformation in the 
MT polymer (Nogales et al., 1999; Gigant et al., 2000; Nogales 
et al., 2003). Other proteins, such as stathmin, cause MT catas-
trophe by binding to and sequestering curved tubulin dimer 
(Cassimeris, 2002), and depolymerizing kinesins may engage 
tubulin tails to peel off dimers at MT ends by fl  ipping them into 
the curved conformation (Wordeman, 2005). Spastin could 
sever MTs by fl  ipping a tubulin heterodimer in the middle of a 
polymer into the curved conformation, making it incompatible 
with polymer packing.
Given that the tubulin tails are present on nonpolymerized 
dimer, one might have expected hexameric Spastin to bind to 
dimer. The fact that it does not (Fig. 7) may mean that the tails 
are not accessible in the dimer but may become exposed or 
properly oriented in the MT polymer either by virtue of some 
polymer-induced conformational change in this region of tubulin 
or by virtue of Spastin binding to the polymer. As mentioned 
earlier, Spastin could conceivably be restricted to MT polymer 
if it indeed interacts preferentially with tubulin in a straight 
  conformation. As Spastin apparently does not interact well with 
soluble dimer, any ATP-driven change in tubulin conformation 
occurring during severing may result in Spastin release from the 
severed tubulin.
Materials and methods
Expression and puriﬁ  cation of Spastin
Expression and puriﬁ  cation of GST-Spastin was as previously described 
(Evans et al., 2005) with the following modiﬁ  cations. Deletions and point 
mutations were made using the QuikChange kit (Stratagene). ∆1–227 
Spastin expressed better and was more soluble than full-length Spastin, 
  resulting in better yields. GST-tagged protein was expressed from the pGEX-
6P-3 vector (GE Healthcare). Protein was expressed using BL21-CodonPlus 
(DE3)-RIPL E. coli (Stratagene). Cultures were grown in LB supplemented 
with carbenicillin, chloramphenicol, and streptomycin to an OD of 1.0 and 
induced overnight at 30°C by adding IPTG to 0.5 mM. Cells were lysed in 
1 ml of lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM MgCl2, 
5 mM DTT, 1 mM ATP, and EDTA-free protease inhibitor tablet [Roche]) per 
20 ml culture using a high-pressure homogenizer (Emulsiﬂ  ex C-5; Avestin). 
Triton X-100 was added to 1% to the lysate at this stage. Detergent was not 
kept in the buffer during puriﬁ  cation. Lysates were cleared by centrifugation 
(Ti60 rotor [Beckman Coulter]; 45,000 rpm, 45 min, 4°C) and pumped 
over a 1- or 5-ml glutathione–Sepharose column (GE Healthcare). The col-
umn was washed with 10 column volumes of lysis buffer with 500 mM 
NaCl and 1 mM DTT (no ATP) followed by 10 column volumes of lysis 
  buffer with 150 mM NaCl and 1 mM DTT (no ATP). Protein was eluted 
  using a gradient of 1–50 mM glutathione in lysis buffer with 1 mM DTT and 
no ATP. For cleavage of the GST moiety, protein was desalted (PD10 
  column; GE Healthcare) into enzyme buffer (50 mM Hepes, pH 7.4, 150 mM 
NaCl, 5 mM MgCl2, and 1 mM DTT) and cut overnight at 4°C with Pre-
Scission Protease (GE Healthcare). Protease and GST were removed using 
glutathione–Sepharose beads (GE Healthcare). ATPase assays of Spastin 
activity by the malachite green method are as described previously (Evans 
et al., 2005). Km and Vmax were calculated by nonlinear regression analysis 
using the Prism 4 software package.
Gel ﬁ  ltration chromatography
Gel ﬁ  ltration chromatography was performed using a Superdex 200 column 
(bed volume = 24 ml) attached to an FPLC (GE Healthcare) system that 
was run at 0.4 ml/min. Typically, 50–100 μg Spastin in a volume of 
100 μl was centrifuged (TL100 rotor [Beckman Coulter]; 50,000 rpm, 
10 min, 4°C) immediately before analysis. 0.4-ml fractions were collected. 
The column was calibrated with the size standards indicted in the ﬁ  gures. 
Typically, the buffer composition was 50 mM Hepes, pH 7.3, 100 mM 
NaCl, 5 mM MgCl2, and 1 mM DTT. Where indicated in the ﬁ  gures, the 
column buffer and the sample contained 1 mM ATP or 0.1 mM ATPγS. 
Sometimes Spastin was concentrated before chromatography using Amicon 
concentrators blocked with 5% Tween-20.
Analytical ultracentrifugation
Sedimentation velocity analysis was performed with an Optima XL-I 
(Beckman Coulter) in aluminum-ﬁ  lled epon double-sector cells at 20°C and 
50,000 rpm. Interference scans were collected at 45-s intervals. Four dilu-
tions of E442Q Spastin, ranging from 0.94 to 0.08 mg/ml, were pre-
pared in 50 mM Hepes, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 
1 mM ATP.
The sedimentation of macromolecules in a centrifugal ﬁ  eld is gov-
erned by the Lamm equation:
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where c is the concentration, t is time, r is the radial distance, D is the 
translation diffusion constant, s is the sedimentation coefﬁ  cient, and ω is 
the rotation velocity. The sedimentation coefﬁ  cient and translation diffusion 
constant were obtained by analysis sedimentation velocity data. These 
  parameters were then used to obtain the molecular weight using the Svedberg 
equation:
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where M is the molecular weight, R is the gas constant, T is the tempera-
ture,  v  is the partial speciﬁ  c volume of the macromolecule, and ρ is the 
solvent density.
We used the program DcDt+ to analyze the association state 
of Spastin. This program computes the apparent sedimentation coefﬁ  cient JCB • VOLUME 176 • NUMBER 7 • 2007  1004
distribution function g(s*), where the peak of the function is related to the 
sedimentation coefﬁ  cient and the width of the function is related to the diffusion 
constant. These parameters are obtained by nonlinear least squares ﬁ  ts to 
the g(s*) functions, and the molecular masses are then computed using the 
Svedberg equation. The data were analyzed using the time-derivative 
method (Stafford, 1992) to obtain normalized g(s*) proﬁ  les with the DcDt+ 
analysis software (Philo, 2000, 2006). The buffer density and the protein 
mass and partial speciﬁ  c volume were calculated using the SEDNTERP 
  program (Laue et al., 1992).
Videomicroscopy, cell culture, transfections, and immunoﬂ  uorescence
Videomicroscopy, cell culture, transfections, and immunoﬂ  uorescence were 
performed as described previously (Evans et al., 2005). Cos-7 cells were 
transfected with Polyfect (QIAGEN) for 36–48 h before being ﬁ  xed  in 
methanol. Tubulin was stained with YL1/2 antibody. In general, Spastin 
was visualized as a YFP fusion, and tubulin was visualized using a Cy5-
  labeled secondary antibody. All images were obtained with a microscope 
(Axiovert 200; Carl Zeiss MicroImaging, Inc.) using a 63× 1.6 NA plan-
apochromat oil-immersion lens. Images were acquired with a CE camera 
(Roper Scientiﬁ   c) using MetaMorph software (Universal Imaging Corp.) 
and processed with Photoshop (Adobe). Site-directed mutagenesis of the 
YFP-Spastin plasmid was achieved using the QuikChange kit.
Spin-down assay for MT severing
The centrifugation or spin-down assay for MT severing is essentially as 
published previously (Evans et al., 2005). For the tubulin tail competi-
tion experiment, 25-μl assays contained 0.5 μg Spastin, 1.0 μg taxol-
  stabilized MTs, and 8.6 μg GST–tubulin tail peptide. The GST–tubulin tail 
construct encodes GST fused to the C-terminal 104 amino acids of murine 
α-tubulin. Recombinant protein production was essentially as described for 
GST-Spastin. Although this protein has Tyr as the ultimate amino acid, we 
also produced a similar peptide corresponding to detyrosinated tubulin 
that ends in Glu. These plasmids were the gift of G. Gundersen (Columbia 
University, New York, NY).
GST–tubulin tail binding assay
8.6 μg of Spastin was added to the aforementioned GST–tubulin tail pep-
tides (6.0 μg) immobilized on glutathione–Sepharose in a total volume of 
100 μl (50 mM Hepes, pH 7.3, 150 mM NaCl, 5 mM MgCl2, and 1 mM 
DTT) with or without 1 mM ATP, as indicated in the ﬁ  gures. After 30 min at 
25°C, beads were washed three times with buffer supplemented with 0.1% 
Triton X-100 and either lacking or containing ATP. Next, SDS-PAGE sample 
buffer was added, and proteins were visualized by Coomassie staining 
  after SDS-PAGE.
EDC cross-linking
EDC (Pierce Chemical Co.) was added to mixtures of proteins to 1–5 mM 
ﬁ  nal from a 50 mM stock. Reaction buffer was 50 mM Hepes, pH 7.4, 
150 mM NaCl, and 5 mM Mgl2. After 15 min at room temperature, reac-
tions were quenched by the addition of SDS-PAGE sample buffer. Samples 
were analyzed by Coomassie blue staining after SDS-PAGE.
Online supplemental material
Fig. S1 shows EDC cross-linking between Spastin and MTs. Fig. S2 shows 
a detailed deletion analysis of the N-terminal MTBD. Fig. S3 shows that 
the C-terminal tail of tubulin is partially protease protected by the Spastin 
  hexamer. Fig. S4 shows the biochemical characterization of Spastin lacking 
the MTBD. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200610072/DC1.
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